DE3580391D1 - Perhydrothiazepin-derivate, ihre herstellung und ihre pharmazeutische anwendung. - Google Patents

Perhydrothiazepin-derivate, ihre herstellung und ihre pharmazeutische anwendung.

Info

Publication number
DE3580391D1
DE3580391D1 DE8585302524T DE3580391T DE3580391D1 DE 3580391 D1 DE3580391 D1 DE 3580391D1 DE 8585302524 T DE8585302524 T DE 8585302524T DE 3580391 T DE3580391 T DE 3580391T DE 3580391 D1 DE3580391 D1 DE 3580391D1
Authority
DE
Germany
Prior art keywords
sup
group
heterocyclic
aryl
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585302524T
Other languages
English (en)
Inventor
Hiroaki Yanagisawa
Sadao Ishihara
Akiko Jpando
Takuro Kanazaki
Hiroyuki Koike
Yoshio Tsujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Sankyo Lifetech Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59071353A external-priority patent/JPS60215678A/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE3580391D1 publication Critical patent/DE3580391D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Hydrogenated Pyridines (AREA)
DE8585302524T 1984-04-10 1985-04-10 Perhydrothiazepin-derivate, ihre herstellung und ihre pharmazeutische anwendung. Expired - Lifetime DE3580391D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59071353A JPS60215678A (ja) 1984-04-10 1984-04-10 ６−アミノ−４−アザ−５−オキソ−１−チアシクロヘプタン誘導体
JP27345184 1984-12-26

Publications (1)

Publication Number Publication Date
DE3580391D1 true DE3580391D1 (de) 1990-12-13

Family

ID=26412460

Family Applications (3)

Application Number Title Priority Date Filing Date
DE8585302524T Expired - Lifetime DE3580391D1 (de) 1984-04-10 1985-04-10 Perhydrothiazepin-derivate, ihre herstellung und ihre pharmazeutische anwendung.
DE1999175024 Active DE19975024I2 (de) 1984-04-10 1985-04-10 Perhydrothiazepin-Derivate, ihre Herstellung und ihre pharmazeutische Anwendung.
DE3587674T Expired - Lifetime DE3587674T2 (de) 1984-04-10 1985-04-10 Perhydrothiazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE1999175024 Active DE19975024I2 (de) 1984-04-10 1985-04-10 Perhydrothiazepin-Derivate, ihre Herstellung und ihre pharmazeutische Anwendung.
DE3587674T Expired - Lifetime DE3587674T2 (de) 1984-04-10 1985-04-10 Perhydrothiazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.

Country Status (15)

Country Link
US (1) US4699905A (de)
EP (2) EP0365045B1 (de)
KR (1) KR900002674B1 (de)
AT (2) ATE97914T1 (de)
AU (1) AU574455B2 (de)
CA (1) CA1266047A (de)
DE (3) DE3580391D1 (de)
DK (2) DK173297B1 (de)
ES (2) ES8702388A1 (de)
FI (1) FI87211C (de)
HU (1) HU193108B (de)
IE (1) IE63903B1 (de)
NZ (1) NZ211718A (de)
RU (1) RU1801110C (de)
SU (1) SU1435151A3 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512988A (en) * 1984-03-01 1985-04-23 E. R. Squibb & Sons, Inc. Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines
JPH0637473B2 (ja) * 1985-10-11 1994-05-18 三共株式会社 ラクタム化合物
ES2061490T3 (es) * 1986-04-04 1994-12-16 Sankyo Co Derivados de perhidrotiazepina y perhidroazepina, su preparacion y uso en terapeutica.
US5041435A (en) * 1988-08-13 1991-08-20 Santen Pharmaceutical Co., Ltd. Cyclic sulfur-containing compounds
US5057513A (en) * 1989-05-25 1991-10-15 Fujisawa Pharmaceutical Co., Ltd. Spiro-thiazepine derivatives useful as paf antagonists
US5646276A (en) * 1992-05-13 1997-07-08 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
RU2124503C1 (ru) 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
KR20110117731A (ko) 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
CN101316626A (zh) * 2005-09-29 2008-12-03 菲布罗根公司 用于降低血压的方法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
AU2006313430B2 (en) 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN100484936C (zh) * 2006-02-27 2009-05-06 上海奥博生物医药技术有限公司 (2s,6r)-6-氨基-2-(2-噻吩基)-1,4-硫氮杂卓-5-酮的合成方法
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
KR101233139B1 (ko) * 2011-04-21 2013-02-21 주식회사 한서켐 라세믹 1,4-티아제핀 화합물의 분할 방법
EP2986599A1 (de) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287203A (en) * 1980-04-23 1981-09-01 Usv Pharmaceutical Corporation Antihypertensive 1,4-thiazepine-ones, 1,4-thiazonine-ones, and method of use thereof
US4587050A (en) * 1980-08-18 1986-05-06 Merck & Co., Inc. Substituted enantholactam derivatives as antihypertensives
IL63540A0 (en) * 1980-08-18 1981-11-30 Merck & Co Inc Substituted enantholactam derivatives as antihypertensives
EP0068173B1 (de) * 1981-06-05 1984-09-26 Merck & Co. Inc. Perhydro-1,4-thiazepin-5-one und Perhydro-1,4-thiazocin-5-one, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4460579A (en) * 1983-02-28 1984-07-17 E. R. Squibb & Sons, Inc. Thiazine and thiazepine containing compounds
US4512988A (en) * 1984-03-01 1985-04-23 E. R. Squibb & Sons, Inc. Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines

Also Published As

Publication number Publication date
FI87211C (fi) 1992-12-10
FI851433A0 (fi) 1985-04-10
FI851433L (fi) 1985-10-11
DK64397A (da) 1997-06-02
RU1801110C (ru) 1993-03-07
DK173255B1 (da) 2000-05-22
EP0161801B1 (de) 1990-11-07
EP0365045A1 (de) 1990-04-25
EP0161801A2 (de) 1985-11-21
KR900002674B1 (ko) 1990-04-23
AU574455B2 (en) 1988-07-07
AU4105885A (en) 1985-10-17
ES557034A0 (es) 1988-01-01
NZ211718A (en) 1988-04-29
ATE97914T1 (de) 1993-12-15
SU1435151A3 (ru) 1988-10-30
DK173297B1 (da) 2000-06-19
FI87211B (fi) 1992-08-31
CA1266047A (en) 1990-02-20
ES8702388A1 (es) 1987-01-01
IE850893L (en) 1985-10-10
DE3587674T2 (de) 1994-06-30
HU193108B (en) 1987-08-28
DE19975024I2 (de) 2004-07-01
DK161185A (da) 1985-10-11
DE3587674D1 (de) 1994-01-13
ES8801229A1 (es) 1988-01-01
DK161185D0 (da) 1985-04-10
US4699905A (en) 1987-10-13
EP0161801A3 (en) 1988-01-13
IE63903B1 (en) 1995-06-14
ES542127A0 (es) 1987-01-01
KR850007799A (ko) 1985-12-09
EP0365045B1 (de) 1993-12-01
HUT37770A (en) 1986-02-28
ATE58146T1 (de) 1990-11-15

Similar Documents

Publication Publication Date Title
DE3580391D1 (de) Perhydrothiazepin-derivate, ihre herstellung und ihre pharmazeutische anwendung.
NO164980C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater.
FI941537A0 (fi) Uudet tehokkaat, terminaalisen erilaistumisen indusoivat aineet sekä menetelmät niiden käyttämiseksi
NO173867C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
ATE88711T1 (de) Glycerol-derivate, ihre herstellung und ihre therapeutische verwendung.
SE8501767D0 (sv) Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
FI851261A0 (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FR2669927B1 (fr) Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
HUT48622A (en) Process for producing hydrogenated 1-(benzoxacycloalkyl)-pyridinecarboxylic acid derivatives and pharmaceutical compositions comprising such compounds
DE3682215D1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
SE8303913L (sv) Heterocykliska foreningar
ATE115145T1 (de) Penem-derivate, ihre herstellung und verwendung.
ES2054186T3 (es) Composicion antihepatopatica.
NO872982D0 (no) Nye tetracykliske indolderivater.
ATE74351T1 (de) Substituierte piperidine oder azepine, ihre herstellung und therapeutische verwendung.
DK574083A (da) 3-aminopropoxyphenylderivater
DE3585070D1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.
FI871424A (fi) Foerfarande foer framstaellning av foereningar med tvao ringar, och nya mellanprodukter.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: TEMOCAPRILHYDROCHLORID; REGISTRATION NO/DATE: 42766.00.00, 19981008

Spc suppl protection certif: 199 75 024

Filing date: 19990309

V457 Spc granted

Free format text: PRODUCT NAME: TEMOCAPRILHYDROCHLORID; REGISTRATION NO/DATE: 42766.00.00, 19981008

Spc suppl protection certif: 199 75 024

Filing date: 19990309

8327 Change in the person/name/address of the patent owner

Owner name: SANKYO LIFETECH CO.LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SANKYO CO., LTD., TOKYO, JP

Owner name: NOVARTIS ANIMAL HEALTH K.K., TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SANKYO CO., LTD., TOKYO, JP

Owner name: SANKYO LIFETECH CO.LTD., TOKIO/TOKYO, JP

V464 Spc expired

Free format text: PRODUCT NAME: TEMOCAPRILHYDROCHLORID; REGISTRATION NO/DATE: 42766.00.00, 19981008

Spc suppl protection certif: 199 75 024

Filing date: 19990309